itraconazole for 5 days

Small molecule

itraconazole for 5 days is one of 5 small molecule programs targeting Pityriasis Versicolor. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pityriasis VersicolorActive, not recruiting

Pityriasis VersicolorPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

6 competitors in Pityriasis Versicolor

#DrugCompanyPhaseTrials

Sporanox

SSebela Pharmaceuticals Development LLC

Approved

2 2

Nizoral

WWim Janssens

Approved

—3

Luzu

BBausch Health Americas, Inc.

Approved

1 4

Diflucan

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 1

2 5

itraconazole for 5 days

CCombined Military Hospital Abbottabad

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pityriasis Versicolor1 trial

Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor

Not yet recruiting·—·Phase 1/2·NCT07331792·86 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for itraconazole for 5 days. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — itraconazole for 5 days compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for itraconazole for 5 days. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Combined Military Hospital Abbottabad company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: CCombined Military Hospital Abbottabad

itraconazole for 5 days

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pityriasis Versicolor1 trial

References

Drug Info

Quick Facts

Related News